Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reproducibility Inter-session of the Measurement Elastography of the Passive Stiffness of Medial Beams of Gastrocnemius Muscle of the Hemiplegic Cerebral Child. (ELASTOREPRO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02960932
Recruitment Status : Completed
First Posted : November 10, 2016
Last Update Posted : September 14, 2017
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Saint Etienne

Brief Summary:
Muscles, paretics and spastics, of cerebral palsy children have very early, for growth (three at five aged), every alteration of theirs properties. Gastrocnemius muscle, often reaches on the cerebral palsy, characterised by a modification of the structure (volume decrease) and the elasticity (increase of the passive stiffness). Every alterations of the muscular property have impact clinic and functional important. The many treatments of orthopaedic targeting (lengthening of cast, injections of botulinic toxin), repeated to a multiple recovery during the growth influences the muscular characteristics. There is a real interest to measure the muscular property development during children's growth.

Condition or disease Intervention/treatment Phase
Gait Child Development Hemiplegic Device: ultrasound scanner Not Applicable

Detailed Description:
Elastography is a technical assessment of characteristic of the soft tissues. In this area, the method " Supersonic Shear Imaging® (SSI) " provide an important technological change measuring, swiftly and no invasive, a elasticity modulus reflecting the property visco-elastic of the muscle. A lot of ex vivo study led in isolated muscle and in vivo in healthy adults demonstrated the validity of the method SSI on the evaluation of the passive stiffness from a number of muscle group whose the gastrocnemius muscle. The main objective of this study must be checked the intersession reproducibility of the method SSI on the evaluation of the passive stiffness at the medial bundle of the gastrocnemius muscle therefore their passive lengthening in cerebral palsy children. The secondary objective is to test the correlation level of the relation elasticity modulus/ joint angle and couple force-angle obtained throughout the passive lengthening at the medial bundle of the gastrocnemius muscle in cerebral palsy children.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 13 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Reproducibility Inter-session of the Measurement Elastography of the Passive Stiffness of Medial Beams of Gastrocnemius Muscle of the Hemiplegic Cerebral Child.
Actual Study Start Date : February 21, 2017
Actual Primary Completion Date : March 10, 2017
Actual Study Completion Date : March 10, 2017

Arm Intervention/treatment
Experimental: hemiplegic cerebral child
Ultrasound scanner used to the SSI technical reproducibility.
Device: ultrasound scanner
Ultrasound scanner used to the SSI technical reproducibility.




Primary Outcome Measures :
  1. Measure of elasticity modulus [ Time Frame: 7 days ]
    To measure at the medial bundle of the gastrocnemius muscle at the passive mobilization of the ankle in the joint sector following: 30 degree in plantar and maximal dorsal flexion; calculation of yield curve of elasticity modulus, joint angle in kilopascals (kPa).


Secondary Outcome Measures :
  1. Measure of force couple [ Time Frame: 7 days ]
    Stored measure at the passive mobilization of the ankle in position of maximal dorsal flexion; calculation of yield couple of joint force-angle in nanometer.

  2. Measure of fascicular length [ Time Frame: 7 days ]
    To measure at the medial bundle of the gastrocnemius muscle at the passive mobilization of the ankle in the selected joint sector (30 degree in plantar and maximal dorsal flexion); calculation of the difference of fascicular length in millimeter between the extreme position of joint sector: 30 degree in plantar and maximal dorsal flexion.

  3. Measure of pennation angle of the muscular fascicle [ Time Frame: 7 days ]
    To measure at the medial bundle of the gastrocnemius muscle at the passive mobilization in the selected joint sector in degree; calculation of the difference of pennation angle of the muscular fascicle between the extreme position of joint sector: 30 degree in plantar and maximal dorsal flexion.

  4. Measure of elasticity modulus [ Time Frame: 7 days ]
    Measure of elasticity modulus at the medial bundle of the gastrocnemius muscle in rest position kilopascals (kPa).

  5. Measure of muscle stiffness [ Time Frame: 7 days ]
    Difference of muscle stiffness evaluated between the paretic and no paretic member.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Parents affiliated or entitled to a social security;
  • Children diagnosed spastic cerebral paralyzed, with a clinical picture of hemiplegia infantile cerebral;
  • Children walking GMFCS (Gross Motor Functional Classification System) between I and III;
  • Children with spasticity level in the paralysing gastrocnemius muscle greater than or equal X1, VII, on the scale of Tardieu and 2 on the Ashworth scale.
  • Children aged 5 to 12 years.
  • Children can understand and follow the simple instructions in the examination process.
  • Consent signed by the holder of parental authority.

Exclusion Criteria:

  • Children with concomitant muscle disease (myopathy ...).
  • Children who received another treatment to target relaxant (baclofen, ... muscle relaxant) which would have begun in the months preceding the assessment.
  • Children who underwent neuro-orthopedic surgery at the where paretic members.
  • Children who received an injection of botulinic toxin for less than 15 days.
  • Children who have benefited from extensions casts for less than 7 days.
  • Children who received a therapeutic target for orthopedic (botulinum toxin, plaster of extensions, installation of equipment of lower limb) between the two sessions evaluations.
  • Children who received a physiotherapy session the day before evaluation elastography and ultrasound.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02960932


Locations
Layout table for location information
France
CHU de Saint Etienne
Saint Etienne, France, 42055
Sponsors and Collaborators
Centre Hospitalier Universitaire de Saint Etienne
Investigators
Layout table for investigator information
Principal Investigator: Vincent Gautheron, MD PhD Centre Hospitalier Universitaire de Saint Etienne
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier: NCT02960932    
Other Study ID Numbers: 1608112
2016-A01558-43 ( Other Identifier: ANSM )
First Posted: November 10, 2016    Key Record Dates
Last Update Posted: September 14, 2017
Last Verified: March 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Centre Hospitalier Universitaire de Saint Etienne:
Hemiplegic
Child
Elastography
paralysis